Abstract:Background: A non-invasive imaging technology that can monitor cell viability, retention, distribution, and interaction with host tissue after transplantation is needed for optimizing and translating stem cell-based therapies. Current cell imaging approaches are limited in sensitivity or specificity, or both, for in vivo cell tracking. The objective of this study was to apply a novel ferritin-based magnetic resonance imaging (MRI) platform to longitudinal tracking of human embryonic stem cells (hESCs) in vivo. Methods: Human embryonic stem cells (hESCs) were genetically modified to stably overexpress ferritin using the CRISPR-Cas9 system. Cellular toxicity associated with ferritin overexpression and manganese (Mn) supplementation were assessed based on cell viability, proliferation, and metabolic activity. Ferritin-overexpressing hESCs were characterized based on stem cell pluripotency and cardiac-lineage differentiation capability. Cells were supplemented with Mn and imaged in vitro as cell pellets on a preclinical 3 T MR scanner. T1-weighted images and T1 relaxation times were analyzed to assess contrast. For in vivo study, three million cells were injected into the leg muscle of non-obese diabetic severe combined immunodeficiency (NOD SCID) mice. Mn was administrated subcutaneously. T1-weighted sequences and T1 mapping were used to image the animals for longitudinal in vivo cell tracking. Cell survival, proliferation, and teratoma formation were non-invasively monitored by MRI. Histological analysis was used to validate MRI results. Results: Ferritin-overexpressing hESCs labeled with 0.1 mM MnCl2 provided significant T1-induced bright contrast on in vitro MRI, with no adverse effect on cell viability, proliferation, pluripotency, and differentiation into cardiomyocytes. Transplanted hESCs displayed significant bright contrast on MRI 24 h after Mn administration, with contrast persisting for 5 days. Bright contrast was recalled at 4-6 weeks with early teratoma outgrowth. Conclusions: The bright-ferritin platform provides the first demonstration of longitudinal cell tracking with signal recall, opening a window on the massive cell death that hESCs undergo in the weeks following transplantation before the surviving cell fraction proliferates to form teratomas.

Research progress of ferritin as a new MRI reporter gene in molecular imaging

MR Molecular Imaging of HCC Employing a Regulated Ferritin Gene Carried by a Modified Polycation Vector.

Construction of a new endogenous MRI reporter gene of mice——the plasmid of ferritin H-chain gene

Design and characterization of a chimeric ferritin with enhanced iron loading and transverse NMR relaxation rate

MRI contrast demonstration of antigen-specific targeting with an iron-based ferritin construct

Ferritin Coordinates with SPIO in Tracking C6 Rat Glioma Cells by MRI

Identification of the reporter gene combination that shows high contrast for cellular level MRI

Research progress in bio-responsive MRI contrast agent

Quantitative MRI Evaluation of Ferritin Overexpression in Non-Small-Cell Lung Cancer

MR molecular imaging of tumours using ferritin heavy chain reporter gene expression mediated by the hTERT promoter

Unveiling the Next Generation of MRI Contrast Agents: Current Insights and Perspectives on Ferumoxytol-Enhanced MRI.

Unveiling the Next Generation of MRI Contrast Agents: Current Insights and Perspectives on Ferumoxytol-Enhanced MRI

Ferritins As Nanoplatforms for Imaging and Drug Delivery

Fluorinated 1,7-DO2A-Based Iron(II) Complexes as Sensitive 19F MRI Molecular Probes for Visualizing Renal Dysfunction in Living Mice

Bright ferritin for long-term MR imaging of human embryonic stem cells

Bioengineered Magnetoferritin Nanoprobes for Single-Dose Nuclear-Magnetic Resonance Tumor Imaging

Narrative review of magnetic resonance imaging in quantifying liver iron load

Ferritin Enhances SPIO Tracking of C6 Rat Glioma Cells by MRI

Ultrasmall Manganese Ferrite Nanoparticles As Positive Contrast Agent For Magnetic Resonance Imaging

MRI for Assessment of Iron Overload in Patients with Hematologic Disease

Quantitative visualization of myocardial ischemia-reperfusion-induced cardiac lesions via ferroptosis magnetic particle imaging